Wednesday, February 10, 2010, 7:32pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Arena Pharmaceuticals, Inc. (ARNA)

At 5:00AM SGT: 3.19 USD   0.00 (0.00%)  
 MORE ON ARNA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Arena Pharmaceuticals, Inc. (NGM:ARNA) Delayed quote dataEdit
Last Trade:3.19 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:3.19
Open:N/A
Bid:0.53 x 500
Ask:3.25 x 500
1y Target Est:6.08
Day's Range:N/A - N/A
52wk Range:2.26 - 7.42
Volume:0
Avg Vol (3m):1,674,990
Market Cap:295.77M
P/E (ttm):N/A
EPS (ttm):-2.33
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ARNA to Portfolio   Download Data

 HEADLINES 
•Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equity
GlobeNewswire (Mon, Feb 8)
•Premarket roundup: Visa, Cisco
AP (Thu, Feb 4)
•Ahead of the Bell: Arena Pharma upgraded
AP (Thu, Feb 4)
•Arena Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
PR Newswire (Thu, Feb 4)
•Arena Pharm upgraded by Rodman & Renshaw
Briefing.com (Thu, Feb 4)
•Orexigen shares rise on Jefferies analyst view
AP (Wed, Feb 3)
•ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
EDGAR Online (Thu, Jan 28)
•Investors betting heavily on Vivus obesity drug
at MarketWatch (Thu, Jan 21)
•The Skinny On Vivus
at CNBC (Thu, Jan 21)
•Fat America
at Forbes.com (Thu, Jan 14)
More Headlines for ARNA...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.80
EPS Est (in 2 years) (Dec-10) :-1.03
Avg Rec (current)*:2.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices